Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
Interventions: DRUG: Administration of ceralasertib|DRUG: Administration of ceralasertib in combination with olaparib|DRUG: Administation of ceralasertib in combination with durvalumab|DRUG: Administration of ceralasertib monotherapy|DRUG: Administration of ceralasertib and olaparib|DRUG: Administration of ceralasertib and durvalumab|DRUG: Administration of ceralasertib in combination with AZD5305|DRUG: Administration of ceralasertib in combination with carboplatin
Sponsor: AstraZeneca